Renovascular hypertension: Screening and modern management

European Heart Journal

Volumn 32, Issue 13, 2011, Pages 1590-1598

  Baumgartner, Iris ^a   Lerman, Lilach O ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b MAYO CLINIC   (United States)

Author keywords

Atherosclerosis; Percutaneous transluminal renal angioplasty; Renovascular disease; Renovascular hypertension

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTIOXIDANT; CAPTOPRIL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE;

ARTICLE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; DRUG ELUTING STENT; DRUG MECHANISM; DRUG MEGADOSE; ENDOTHELIAL PROGENITOR CELL; FIBROMUSCULAR DYSPLASIA; HEART HEMODYNAMICS; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY SCINTISCANNING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; SCREENING TEST;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY, BALLOON; ANGIOTENSIN RECEPTOR ANTAGONISTS; ATHEROSCLEROSIS; DRUG-ELUTING STENTS; EARLY DIAGNOSIS; FIBROMUSCULAR DYSPLASIA; HEMODYNAMICS; HUMANS; HYPERTENSION, RENOVASCULAR; MAGNETIC RESONANCE IMAGING; RENAL ARTERY OBSTRUCTION; RENIN-ANGIOTENSIN SYSTEM; REPERFUSION; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 79959981043     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq510     Document Type: Article

References (68)

1. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002;36:443-451.
2. Buller CE, Nogareda JG, Ramanathan K, Ricci DR, Djurdjev O, Tinckam KJ, Penn IM, Fox RS, Stevens LA, Duncan JA, Levin A. The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol 2004;43:1606-1613. (Pubitemid 38561341)
3. United States Renal Data System U. Annual Data Report. Bethesda, Maryland: US Department of Health and Human Services/National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases; 1997.
4. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001;37:1184-1190. (Pubitemid 32525154)
5. Mui KW, Sleeswijk M, van den Hout H, van Baal J, Navis G, Woittiez AJ. Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J Am Soc Nephrol 2006;17:2069-2074. (Pubitemid 44036191)
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
7. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004;351:1344-1346. (Pubitemid 39258430)
8. Dworkin LD, Murphy T. Is there any reason to stent atherosclerotic renal artery stenosis? Am J Kidney Dis 2010;56:259-263.
9. Wright JR, Duggal A, Thomas R, Reeve R, Roberts IS, Kalra PA. Clinicopathologi-cal correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant 2001;16:765-770. (Pubitemid 32257973)
10. Losito A, Fagugli RM, Zampi I, Parente B, de Rango P, Giordano G, Cao P. Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens 1996;9:1062-1067. (Pubitemid 26383488)
11. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999;17: 1743-1750.
12. White CJ, Jaff MR, Haskal ZJ, Jones DJ, Olin JW, Rocha-Singh KJ, Rosenfield KA, Rundback JH, Linas SL. Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation 2006;114:1892-1895.
13. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, Cantwell-Gab K, Davidson RC, Strandness DE Jr. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866-2872. (Pubitemid 29003969)
14. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE Jr. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg 1994;19:250-257; discussion 257-8.
15. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, Dees A, Woittiez AJ, Bartelink AK, Manin't Veld AJ, Schalekamp MA. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342:1007-1014. (Pubitemid 30180647)
16. Crowley JJ, Santos RM, Peter RH, Puma JA, Schwab SJ, Phillips HR, Stack RS, Conlon PJ. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 1998;136:913-918. (Pubitemid 28506893)
17. Pearce JD, Craven BL, Craven TE, Piercy KT, Stafford JM, Edwards MS, Hansen KJ. Progression of atherosclerotic renovascular disease: a prospective population-based study. J Vasc Surg 2006;44:955-962; discussion 962-3. (Pubitemid 46107243)
18. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004;350:1862-1871.
19. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344:431-442. (Pubitemid 32128677)
20. Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer HT, Seyahi E, Akar S, Onen F, Cefle A, Aydin SZ, Yilmaz N, Onat AM, Cobankara V, Tunc E, Ozturk MA, Fresko I, Karaaslan Y, Akkoc N, Yucel AE, Kiraz S, Keser G, Inanc M, Direskeneli H. Takayasu's arteritis in Turkey\clinical and angiographic features of 248 patients. Clin Exp Rheumatol 2009;27:59-64.
21. Sangle SR, D'Cruz DP, Jan W, Karim MY, Khamashta MA, Abbs IC, Hughes GRV. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis 2003;62:999-1002. (Pubitemid 37159501)
22. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr., White CJ, White J, White RA, Antman EM, Smith SC Jr., Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease: a collaborative report from the American Association fro Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines. Circulation 2006;113: 463e-654e.
23. De Bruyne B, Manoharan G, Pijls NH, Verhamme K, Madaric J, Bartunek J, Vanderheyden M, Heyndrickx GR. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 2006;48:1851-1855. (Pubitemid 44648618)
24. Drieghe B, Madaric J, Sarno G, Manoharan G, Bartunek J, Heyndrickx GR, Pijls NHJ, De Bruyne B. Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur Heart J 2008;29:517-524. (Pubitemid 351264191)
25. Zhang HL, Sos TA, Winchester PA, Gao J, Prince MR. Renal artery stenosis: imaging options, pitfalls, and concerns. Prog Cardiovasc Dis 2009;52:209-219.
26. Slovut DP. Screening renal angiography as a routine part of cardiac catheteriza-tion: a reappraisal. Vasc Med 2009;14:271-275.
27. Baumgartner I, Behrendt P, Rohner P, Baumgartner RW. A validation study on the intraobserver and interobserver reproducibility of renal artery duplex ultrasound. Ultrasound Med Biol 1999;25:225-231. (Pubitemid 29133229)
28. Zeller T, Bonvini RF, Sixt S. Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization. Catheter Car-diovasc Interv 2008;71:995-999. (Pubitemid 351951330)
29. American Institute of Ultrasound in Medicine ACoR. AIUM practice guideline for the performance of renal artery duplex sonography. J Ultrasound Med 2009;28: 120-124.
30. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344:410-417. (Pubitemid 32128673)
31. Rocha-Singh K, Jaff MR, Lynne Kelley E. Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv 2008;72:853-862.
32. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001;37:541-546. (Pubitemid 32199025)
33. Rognant N, Rouviere O, Janier M, Le QH, Barthez P, Laville M, Juillard L. Hemodynamic responses to acute and gradual renal artery stenosis in pigs. Am J Hypertens 2010;23:1216-1219.
34. Safian RD, Madder RD. Refining the approach to renal artery revascularization. JACC Cardiovasc Interv 2009;2:161-174.
35. Chade AR, Zhu XY, Krier JD, Jordan KL, Textor SC, Grande JP, Lerman A, Lerman LO. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 2010;28:1039-1047.
36. Zhu XY, Chade AR, Rodriguez-Porcel M, Bentley MD, Ritman EL, Lerman A, Lerman LO. Cortical microvascular remodeling in the stenotic kidney. role of increased oxidative stress. Arterioscler Thromb Vasc Biol 2004;24:1854-1859. (Pubitemid 39350303)
37. Juillard L, Janier MF, Fouque D, Lionnet M, Le Bars D, Cinotti L, Barthez P, Gharib C, Laville M. Renal blood flow measurement by positron emission tomography using 15O-labeled water. Kidney Int 2000;57:2511-2518. (Pubitemid 30340749)
38. Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, Grande JP, Gomez SI, Romero JC. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008;19:780-788.
39. Hanzel G, Balon H, Wong O, Soffer D, Lee DT, Safian RD. Prospective evaluation of aggressive medical therapy for atherosclerotic renal artery stenosis, with renal artery stenting reserved for previously injured heart, brain, or kidney. Am J Cardiol 2006;96:1322-1327. (Pubitemid 41505418)
40. Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O'Donoghue DJ, Waldek S, Kalra PA. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002;13:149-157. (Pubitemid 34042022)
41. Uzu T, Takeji M, Yamada N, Fujii T, Yamauchi A, Takishita S, Kimura G. Prevalence and outcome of renal artery stenosis in atherosclerotic patients with renal dysfunction. Hypertens Res 2002;25:537-542.
42. Hackam DG, Spence JD, Garg AX, Textor SC. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension 2007;50:998-1003. (Pubitemid 350172917)
43. Chade AR, Zhu XY, Grande JP, Krier JD, Lerman A, Lerman LO. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens 2008;26:1651-1660.
44. Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, Napoli C, Lerman A, Lerman LO. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009;119:547-557.
45. Duranay M, Kanbay M, Akay H, Unverdi S, Surer H, Altay M, Kirbas I, Covic A, Zoccali C. Nebivolol improves renal function in patients who underwent angio-plasty due to renal artery stenosis: a pilot study. Nephron Clin Pract 2010;114: c213-c217.
46. Balk E, Raman G. Comparative effectiveness of management strategies for renal artery stenosis: 2007 update. AHRQ Comparative Effectiveness Reviews 2007; Report No. 07(08)-EHCoo4-U-EF.
47. Leesar MA, Varma J, Shapira A, Fahsah I, Raza ST, Elghoul Z, Leonard AC, Meganathan K, Ikram S. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol 2009;53:2363-2371.
48. Kalra PA, Chrysochou C, Green D, Cheung CM, Khavandi K, Sixt S, Rastan A, Zeller T. The benefit of renal artery stenting in patients with atheromatous reno-vascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv 2010;75:1-10.
49. Goncalves JA, Amorim JE, Soares Neto MM, Ribeiro AB, Lima VC. Clinical efficacy of percutaneous renal revascularization with stent placement in atherosclerotic renovascular disease. Arq Bras Cardiol 2007;88:85-90.
50. Kalra PA. Renal revascularization for heart failure in patients with atherosclerotic renovascular disease. Nephrol Dial Transplant 2010;25:661-663.
51. Baumgartner I, von Aesch K, Do DD, Triller J, Birrer M, Mahler F. Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: a prospective follow-up study. Radiology 2000;216:498-505. (Pubitemid 30599873)
52. Beutler JJ, Van Ampting JM, Van De Ven PJ, Koomans HA, Beek FJ, Woittiez AJ, Mali WP. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 2001;12:1475-1481. (Pubitemid 32666330)
53. Chaikof EL, Smith RB, Salam AA, Dodson TF, Lumsden AB, Kosinski AS, Coyle KA, Allen RC. Ischemic nephropathy and concomitant aortic disease: a ten year experience. J Vasc Surg 1994;19:135-148. (Pubitemid 24060188)
54. Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K, He T. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-647. (Pubitemid 28387490)
55. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angio-plasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicen-trique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31: 823-829. (Pubitemid 28108582)
56. Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 2010;25:813-820.
57. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361: 1953-1962.
58. Bax L, Woittiez A-JJ, Kouwenberg HJ, Mali WPTM, Buskens E, Beek FJA, Braam B, Huysmans FTM, Schultze Kool LJ, Rutten MJCM, Doorenbos CJ, Aarts JCNM, Rabelink TJ, Plouin P-Fo, Raynaud A, van Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PMT, van de Ven PJG, Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function. Ann Int Med 2009; 150:840-848.
59. Connolly JO, Higgins RM, Walters HL, Mackie AD, Drury PL, Hendry BM, Scoble JE. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM 1994;87:413-421. (Pubitemid 24221346)
60. Cooper CJ. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006;152:59-66. (Pubitemid 43974724)
61. Schwarzwalder U, Hauk M, Zeller T. RADAR\a randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials 2009;10:60.
62. Zahringer M, Sapoval M, Pattynama PM, Rabbia C, Vignali C, Maleux G, Boyer L, Szczerbo-Trojanowska M, Jaschke W, Hafsahl G, Downes M, Beregi JP, Veeger NJ, Stoll HP, Talen A. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther 2007;14:460-468. (Pubitemid 350154991)
63. Cooper CJ. Embolic protection and platelet inhibition during renal artery stenting. Circulation 2008;117:2752-2760. (Pubitemid 351771335)
64. Kanjwal K, Cooper CJ, Virmani R, Haller S, Shapiro JI, Burket MW, Steffes M, Brewster P, Zhang H, Colyer WR Jr. Predictors of embolization during protected renal artery angioplasty and stenting: Role of antiplatelet therapy. Catheter Cardi-ovasc Interv 2010;76:16-23.
65. Reilly JM, Rubin BG, Thompson RW, Allen BT, Anderson CB, Sicard GA. Long-term effectiveness of extraanatomic renal artery revascularization. Surgery 1994; 116:784-791. (Pubitemid 24314226)
66. Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of revas-cularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010;56:525-532.
67. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005;112:1362-1374. (Pubitemid 41266733)
68. Korsakas S, Mohaupt MG, Dinkel HP, Mahler F, Do DD, Voegele J, Baumgartner I. Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Int 2004;65:251-258. (Pubitemid 38037511)